October 2016 – Policy & Medicine

Open Payments Having an Adverse Effect on Physician-Rep Relationships

CMS Posts Revised FAQ, Clarifying that Support for Independent CME is Not to Be Reported

Helping the Patient – Co-Pay Reimbursement Can Be Okay in Certain Circumstances

California to Allow Experimental Drug Treatments for Terminally Ill Patients

The Blue Ribbon Panel Raises the Bar on Ethics & Compliance

Representative Lieu Laser-Focused on Device Act, Olympus

Like Taxes and Inflation – HHS Revises Civil Monetary Penalties Upwards

CMS Bundled Payments for Care Improvement Evaluation Released

BMS Settles with California Insurance Commission – Seems Everyone Is Getting Into the Act

FDA Raises Issue of Citizen Petitions